Respiratory syncytial virus (RSV) is a common, highly contagious illness that affects the nose, throat, and lungs. Although RSV usually causes mild illness with cold-like symptoms, the infection can ...
Respiratory syncytial virus (RSV) is an infection that can be passed from children to adults. While most healthy adults with RSV infection usually can be treated at home, older infected adults may be ...
The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information for the Abrysvo (Pfizer) and Arexvy (GlaxoSmithKline) respiratory syncytial ...
Flu season might soon be dubbed “sick season” as a cocktail of respiratory viruses, including influenza, COVID-19, and respiratory syncytial virus (RSV), surges across the United States.
Sanofi is trailing behind GSK and Pfizer when it comes to vaccines for respiratory syncytial virus (RSV), but it still thinks it can be the top player in the market with a combination of its ...
Already competing to bring the first vaccine against respiratory syncytial virus (RSV) to market, Pfizer and GSK are also fighting a patent infringement battle in the courts. Earlier this month ...
Doctors in Kolkata are observing an increase in respiratory infections among children, particularly with the RSV virus, which is more concerning than Human Metapneumovirus. Many children ...
RSV can cause a runny nose, congestion, coughing ... COVID-19 generally spreads through the air from droplets and particles, and the CDC says the risk of getting the virus from a contaminated surface ...